Teprotumumab for the treatment of thyroid eye disease
Authors:
- 2 August 2020
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 16 (8) , 739-743
Abstract
Thyroid eye disease is a debilitating, disfiguring, and potentially blinding periocular condition. Teprotumumab is a human insulin-like growth factor-I receptor monoclonal inhibitor antibody which ...Keywords
Funding Information
- funded
This publication has 39 references indexed in Scilit:
- Bidirectional TSH and IGF-1 Receptor Cross Talk Mediates Stimulation of Hyaluronan Secretion by Graves' Disease ImmunoglobinsThe Journal of Clinical Endocrinology & Metabolism, 2015
- Randomized Controlled Trial of Rituximab in Patients With Graves' OrbitopathyThe Journal of Clinical Endocrinology & Metabolism, 2015
- Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in FibrocytesThe Journal of Clinical Endocrinology & Metabolism, 2014
- A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration studyCancer, 2014
- Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathyBest Practice & Research Clinical Endocrinology & Metabolism, 2012
- R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration StudyJournal of Clinical Oncology, 2011
- CD8+CD28− Lymphocytes in Peripheral Blood and Serum Concentrations of Soluble Interleukin 6 Receptor are Increased in Patients with Graves’ Orbitopathy and Correlate with Disease ActivityEndocrine Research, 2011
- A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid TumorsClinical Cancer Research, 2010
- Azathioprine in the treatment of thyroid-associated ophthalmopathyEuropean Journal of Endocrinology, 1990
- Prednisone and Cyclosporine in the Treatment of Severe Graves' OphthalmopathyNew England Journal of Medicine, 1989